LL64 57344 (Caffeine 200 mg)
Pill imprint LL64 57344 has been identified as Caffeine 200 mg.
Caffeine is used in the treatment of hypersomnia; apnea of prematurity; asthma and belongs to the drug class CNS stimulants. Caffeine Citrate Injection: Risk cannot be ruled out during pregnancy. Excluding Caffeine Citrate Injection: FDA has not classified the drug for risk during pregnancy. Caffeine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- LL64 57344
- Strength:
- 200 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out - Caffeine Citrate Injection
N - Not classified - excluding Caffeine Citrate Injection - CSA Schedule:
- Not a controlled drug
- Manufacturer:
- AAA Pharmaceutical, Inc.
More about caffeine
Consumer resources
- Caffeine Citrate
- Caffeine
- Caffeine solution
- Caffeine (Advanced Reading)
- Caffeine citrate Intravenous (Advanced Reading)
- Other brands: Vivarin, Cafcit, NoDoz, Lucidex, More (2) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
